Telisotuzumab vedotin (anti-c-Met) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin (anti-c-Met) consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin (anti-c-Met) can be used in cancer research. Purity >90% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
规格
产品名称
Telisotuzumab vedotin (anti-c-Met), 微管蛋白抑制剂
别名
特立妥珠单抗
英文别名
AUTS9 antibody | c met antibody | D249 antibody | Hepatocyte growth factor receptor antibody | HGF antibody | HGF receptor antibody | HGF/SF receptor antibody | HGFR antibody | MET antibody | Met proto oncogene antibody | Met proto oncogene tyrosine kinas
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, pH5.0.
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - Flow Cytometry Flow Cytometry analysis of Hela cells labelling c-Met (red) with Telisotuzumab vedotin (anti-c-Met) (Ab183336). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - Flow Cytometry Flow Cytometry analysis of A549 cells labelling c-Met (red) with Telisotuzumab vedotin (anti-c-Met) (Ab183336). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - ELISA Immobilized Human HGFR/c-MET protein (rp169642) at 1.0 μg/mL can bind Telisotuzumab vedotin (anti-c-Met) (Ab183336) with the EC50 of 298.4 ng/mL.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - SEC The purity of Telisotuzumab vedotin (anti-c-Met) (Ab183336) is more than 95% verified by HPLC.